Filing Flows

Filing Flows › Traws Pharma (TRAW) › Who owns the stock

Who owns Traws Pharma (TRAW) stock

32 funds reported Traws Pharma (TRAW) shares in their latest 13F filings, worth $5.1M in all. The largest holder is Orbimed Advisors LLC ($1.0M). Last quarter 18 funds added to their stakes and 15 cut them.

Largest holders of TRAW (13F)Largest holders of TRAW (13F)Orbimed Advisors LLC$1.0MAlly Bridge Group (NY) LLC$663KAdage Capital Partners GP, L.L.C.$616KADAR1 Capital Management, LLC$504KLynx1 Capital Management LP$472KIkarian Capital, LLC$403KSphera Funds Management$336KVanguard Capital Management LLC$278KJane Street Group, LLC$182KAlyeska Investment Group, L.P.$139K

Largest holders (13F)

FundSharesValueChangeQuarter
Orbimed Advisors LLC1,203,260$1.0Mincrease2026-06-30
Ally Bridge Group (NY) LLC786,236$663Knew2026-06-30
Adage Capital Partners GP, L.L.C.730,000$616Kunchanged2026-06-30
ADAR1 Capital Management, LLC597,729$504Kincrease2026-06-30
Lynx1 Capital Management LP559,470$472Kincrease2026-06-30
Ikarian Capital, LLC478,142$403Kdecrease2026-06-30
Sphera Funds Management398,486$336Knew2026-06-30
Vanguard Capital Management LLC330,049$278Kincrease2026-06-30
Jane Street Group, LLC216,006$182Kincrease2026-06-30
Alyeska Investment Group, L.P.164,376$139Knew2026-06-30
Boothbay Fund Management, LLC133,936$113Kdecrease2026-06-30
Vanguard Group87,259$99Kunchanged2025-12-31
Geode Capital Management, LLC111,365$94Kincrease2026-06-30
Kynam Capital Management, LP84,400$71Knew2026-06-30
Vanguard Fiduciary Trust54,511$46Kincrease2026-06-30

Traws Pharma's latest quarter

Traws Pharma, Q2 2025: revenue $2.7M (48× year over year), operating margin -45.7%, net loss $915K, operating cash flow −$6.0M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most TRAW stock?

By the latest 13F filings: Orbimed Advisors LLC ($1.0M); Ally Bridge Group (NY) LLC ($663K); Adage Capital Partners GP, L.L.C. ($616K); ADAR1 Capital Management, LLC ($504K); Lynx1 Capital Management LP ($472K).

What is the short interest in TRAW?

685,721 shares were sold short at the 2026-10-15 settlement, -0.72% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.